PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children

NCT01734512 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
65
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of California, San Francisco

Collaborators